Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG42989

CCDC186 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

CCDC186 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HeLa cervical adenocarcinoma cells. These cells harbor targeted disruption of the CCDC186 gene, encoding a ciliary trafficking protein essential for retrograde intraflagellar transport and Hedgehog signaling. Loss of CCDC186 impairs ciliary localization of Smoothened and GPCRs, disrupting GLI transcription factor activation. The polyclonal format provides a heterogeneous knockout pool ideal for bulk functional studies. Applications include investigation of ciliary trafficking mechanisms, Hedgehog pathway dysregulation in cancer, ciliopathy modeling, and screening for modulators of ciliogenesis and GPCR signaling using immunofluorescence, western blotting, and RT-qPCR.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    CCDC186

    Gene Identifier

    NCBI Gene ID 55088

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

CCDC186 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from HeLa cells, providing a loss-of-function model for studying CCDC186. The polyclonal format yields a pool of cells with targeted gene disruption, suitable for bulk functional assays and pooled screening applications.

HeLa is a human cervical adenocarcinoma epithelial cell line with integrated HPV18 sequences, extensively used in cancer biology for investigating tumorigenesis and cell cycle dysregulation. Under serum starvation, HeLa cells assemble primary cilia, enabling studies of ciliary trafficking and Hedgehog signaling in a cancer-relevant setting.

The CCDC186 protein is an essential component of retrograde intraflagellar transport (IFT), facilitating the return of signaling proteins from the ciliary tip. It interacts with IFT88, IFT140, and BBSome subunits within IFT-A/B complexes. Its expression is controlled by RFX transcription factors and FOXJ1. Loss of CCDC186 disrupts ciliary localization of Smoothened (SMO) and GPCRs such as SSTR3 and HTR6, leading to impaired activation of GLI transcription factors and altered expression of Hedgehog targets like GLI1 and PTCH1.

In HeLa cells, CCDC186 knockout perturbs cilia-dependent signaling, offering a platform to investigate Hedgehog pathway dysregulation in cancer. Given the HPV18-driven oncogenic background, this model can be used to explore how viral oncoproteins modulate ciliary function and how ciliary defects influence tumor cell proliferation and survival. Although CCDC186 mutations are associated with ciliopathies such as neurodevelopmental disorder with obesity and retinal dystrophy, this knockout model in a cancer cell line provides insights into the broader role of ciliary trafficking in cellular homeostasis and disease.

Typical applications include ciliogenesis assays under serum starvation, immunofluorescence detection of ciliary markers ARL13B and acetylated tubulin, SMO translocation assays, and western blot analysis of GLI3 processing to assess full-length and repressor forms. Transcriptional profiling of Hedgehog target genes GLI1 and PTCH1 by RT-qPCR, along with co-immunoprecipitation of IFT components and flow cytometry for ciliated cell quantification, provide robust readouts for pathway activity. These polyclonal knockout cells are also valuable for screening chemical or genetic modulators of ciliogenesis and GPCR ciliary signaling. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)